246 related articles for article (PubMed ID: 2187813)
1. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide.
Schlageter AM; Kozel TR
Infect Immun; 1990 Jun; 58(6):1914-8. PubMed ID: 2187813
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.
Mukherjee S; Lee SC; Casadevall A
Infect Immun; 1995 Feb; 63(2):573-9. PubMed ID: 7822024
[TBL] [Abstract][Full Text] [Related]
3. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
Netski D; Kozel TR
Infect Immun; 2002 Jun; 70(6):2812-9. PubMed ID: 12010967
[TBL] [Abstract][Full Text] [Related]
4. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.
Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD
Infect Immun; 2001 Oct; 69(10):6445-55. PubMed ID: 11553589
[TBL] [Abstract][Full Text] [Related]
5. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice.
Yuan RR; Spira G; Oh J; Paizi M; Casadevall A; Scharff MD
Infect Immun; 1998 Mar; 66(3):1057-62. PubMed ID: 9488395
[TBL] [Abstract][Full Text] [Related]
6. Generation of biologically active anti-Cryptococcus neoformans IgG, IgE and IgA isotype switch variant antibodies by acridine orange mutagenesis.
Spira G; Paizi M; Mazar S; Nussbaum G; Mukherjee S; Casadevall A
Clin Exp Immunol; 1996 Sep; 105(3):436-42. PubMed ID: 8809131
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.
Eckert TF; Kozel TR
Infect Immun; 1987 Aug; 55(8):1895-9. PubMed ID: 2440810
[TBL] [Abstract][Full Text] [Related]
8. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
Kozel TR; Follette JL
Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of sandwich enzyme-linked immunosorbent assay for Cryptococcus neoformans polysaccharide antigen is dependent on the isotypes of the capture and detection antibodies.
Mukherjee S; Casadevall A
J Clin Microbiol; 1995 Mar; 33(3):765-8. PubMed ID: 7751394
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide.
Sanford JE; Lupan DM; Schlageter AM; Kozel TR
Infect Immun; 1990 Jun; 58(6):1919-23. PubMed ID: 2341184
[TBL] [Abstract][Full Text] [Related]
11. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
Kozel TR; Gotschlich EC
J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
[TBL] [Abstract][Full Text] [Related]
12. Isotype can affect the fine specificity of an antibody for a polysaccharide antigen.
McLean GR; Torres M; Elguezabal N; Nakouzi A; Casadevall A
J Immunol; 2002 Aug; 169(3):1379-86. PubMed ID: 12133962
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
Nussbaum G; Yuan R; Casadevall A; Scharff MD
J Exp Med; 1996 Apr; 183(4):1905-9. PubMed ID: 8666947
[TBL] [Abstract][Full Text] [Related]
14. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.
Dromer F; Salamero J; Contrepois A; Carbon C; Yeni P
Infect Immun; 1987 Mar; 55(3):742-8. PubMed ID: 3546139
[TBL] [Abstract][Full Text] [Related]
15. Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.
McGaw TG; Kozel TR
Infect Immun; 1979 Jul; 25(1):262-7. PubMed ID: 383615
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.
Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z
Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223
[TBL] [Abstract][Full Text] [Related]
17. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.
Kozel TR; McGaw TG
Infect Immun; 1979 Jul; 25(1):255-61. PubMed ID: 383614
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous expression of kappa and lambda light chains in a murine IgG3 anti-Cryptococcus neoformans hybridoma cell line.
Spira G; Yuan R; Paizi M; Weisendal M; Casadevall A
Hybridoma; 1994 Dec; 13(6):531-5. PubMed ID: 7737677
[TBL] [Abstract][Full Text] [Related]
19. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
Duro RM; Netski D; Thorkildson P; Kozel TR
Clin Diagn Lab Immunol; 2003 Mar; 10(2):252-8. PubMed ID: 12626451
[TBL] [Abstract][Full Text] [Related]
20. Protective murine monoclonal antibodies to Cryptococcus neoformans.
Mukherjee J; Scharff MD; Casadevall A
Infect Immun; 1992 Nov; 60(11):4534-41. PubMed ID: 1398966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
